Can Novarel be effectively used for patients with diminished ovarian reserve, and how does it address challenges in follicular stimulation and oocyte maturation in this population?
Share
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Can Novarel be effectively used for patients with diminished ovarian reserve, and how does it address challenges in follicular stimulation and oocyte maturation in this population?
Novarel, a form of hCG, is used in IVF to promote final oocyte maturation and follicular stimulation, potentially aiding those with diminished ovarian reserve (DOR).
Novarel, an hCG-based drug, may enhance follicular response and oocyte maturity in those with diminished ovarian reserve by mimicking LH surges.
Novarel can be used in patients with diminished ovarian reserve to stimulate follicles and improve oocyte maturation, but results might vary based on individual response.